For the year ending 2025-12-31, MRNA made $1,944M in revenue. -$2,822M in net income. Net profit margin of -145.16%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total revenue | 1,944 | 3,236 | 6,848 | 19,263 |
| Cost of sales | 868 | 1,464 | 4,693 | 5,416 |
| Research and development | 3,132 | 4,543 | 4,845 | 3,295 |
| Selling, general and administrative | 1,018 | 1,174 | 1,549 | 1,132 |
| Total operating expenses | 5,018 | 7,181 | 11,087 | 9,843 |
| Loss from operations | -3,074 | -3,945 | -4,239 | 9,420 |
| Interest income | 314 | 425 | 421 | 200 |
| Other expense, net | -8 | -87 | -124 | -45 |
| Loss before income taxes | -2,768 | -3,607 | -3,942 | 9,575 |
| Provision for (benefit from) tax provision | 54 | -46 | 772 | 1,213 |
| Net loss | -2,822 | -3,561 | -4,714 | 8,362 |
| Basic (in shares) | 389,000,000 | 384,000,000 | 382,000,000 | 394,000,000 |
| Basic (in usd per share) | -7.26 | -9.28 | -12.33 | 21.26 |
| Diluted (in shares) | 389,000,000 | 384,000,000 | 382,000,000 | 416,000,000 |
| Diluted (in usd per share) | -7.26 | -9.28 | -12.33 | 20.12 |
Moderna, Inc. (MRNA)
Moderna, Inc. (MRNA)